Leigh-Anne Lagden was given a free weight loss injection in exchange for social media promotion but claims they told her to ...

Microdosing isn’t nearly as easy with tirzepatide (Mounjaro ... and using the incorrect click chart could result in a very wrong and possibly dangerous dose. These risks are likely more serious ...

2 Top Growth Stocks to Buy on the Dip was originally published by The Motley Fool ...

Unplanned pregnancies are still being reported among people using GLP-1 drugs, but now fertility specialists are ...

Chart: The Economist What is more ... been reluctant to cover the cost of using GLP-1s for weight loss (a smaller dose is prescribed for diabetes). In America, the largest market by far for ...

For patients with obesity and prediabetes, three years of tirzepatide yields substantial and sustained weight reductio ...

Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...

The current analysis involved the participants with both obesity and prediabetes, who received their assigned dose of tirzepatide or placebo for a total of 176 weeks, followed by a 17-week off ...

A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...

Tirzepatide, administered weekly via injection, significantly ‘decreased’ the risk of developing T2D compared to placebo over 176 weeks. At the highest 15mg dose, participants showed sustained ...

Tirzepatide demonstrated sustained average weight loss of 22.9% (15 mg dose) through the three-year treatment period. The study showed an association of tirzepatide treatment with improved ...

By Dr. Sushama R. Chaphalkar, PhD. A long-term study reveals how tirzepatide not only cuts weight but also slashes diabetes ...